Anti-BRG1 antibody [EPR3913]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal BRG1 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
BAF190A, BRG1, SNF2B, SNF2L4, SMARCA4, Transcription activator BRG1, ATP-dependent helicase SMARCA4, BRG1-associated factor 190A, Mitotic growth and transcription activator, Protein BRG-1, Protein brahma homolog 1, SNF2-beta, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4
- WB
Unknown
Western blot - Anti-BRG1 antibody [EPR3913] (AB92496)
All lanes:
Western blot - Anti-BRG1 antibody [EPR3913] (ab92496) at 1/1000 dilution
Lane 1:
K562 cell lysate at 10 µg
Lane 2:
MOLT4 cell lysate at 10 µg
Secondary
All lanes:
goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 185 kDa
false
- WB
Lab
Western blot - Anti-BRG1 antibody [EPR3913] (AB92496)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : BRG1 knockout HAP1 cell lysate (20 μg)
Lane 3 : K562 cell lysate (20 μg)
Lane 4 : Molt-4 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab92496 observed at 185 kDa. Red - loading control, ab18058, observed at 124 kDa.
ab92496 was shown to recognize BRG1 when BRG1 knockout samples were used, along with additional cross-reactive bands. Wild-type and BRG1 knockout samples were subjected to SDS-PAGE. ab92496 and ab18058 (loading control to Vinculin) were diluted 1/1000 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with goat anti-rabbit IgG (H + L) and goat anti-mouse IgG (H + L) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BRG1 antibody [EPR3913] (ab92496)
Predicted band size: 185 kDa
Observed band size: 185 kDa
false
Related conjugates and formulations (1)
-
Anti-BRG1 antibody [EPR3913] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:1507 PubMed41044515
2025
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 35:582-590 PubMed31875359
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com